Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between 18 and 75 years of age at the time of enrolling in the trial
- People who have a medical reason to undergo a specific procedure to measure pressure in the liver's blood vessels, or to have a liver tissue sample taken through the neck vein, due to long-term serious liver disease
Who may not be able to join:
- People with serious other health conditions, such as advanced heart failure, severe kidney disease (stage 4 or higher), or long-term poorly controlled diabetes with major complications
- People who are pregnant
- People who are not expected to follow the trial's requirements, or who do not agree to sign the consent form
- People with a documented allergy to iodine-based contrast dye (a substance used in some medical imaging)
- People who have a blood clot in the portal vein, a transformed or blocked portal vein, or a blockage of the liver's veins
- People with a severe level of fluid build-up in the abdomen (Grade 3 ascites)
- People with a blockage in the bile ducts
- People who are on blood-thinning or anti-clotting medication that cannot be safely stopped
- People whose blood clotting results are outside certain ranges — specifically, an INR above 1.5 or a platelet count below 50,000 per microlitre (confirm with trial site if unsure about recent test results)
- People who have liver cancer located in the left side of the liver
- People who have had surgery that has changed the normal structure of the upper digestive tract
- People who have previously had a procedure called a transjugular intrahepatic portosystemic shunt (a type of shunt placed in the liver)
- People who have previously received a liver transplant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Petr Hříbek, MD, PhD, Military University Hospital, Prague
Phone: +420973203065
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluation of the consistency between the HVPG and EUS-PPG
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.